Koers China Resources Boya Bio-pharmaceutical Group Co.,Ltd
Aandelen
300294
CNE100001FF1
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
31,28 CNY | -0,29% | -1,14% | -7,13% |
Omzet 2024 * | 1,91 mld. 263 mln. 246 mln. | Omzet 2025 * | 2,08 mld. 287 mln. 268 mln. | Marktkapitalisatie | 15,77 mld. 2,18 mld. 2,04 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 549 mln. 75,77 mln. 70,86 mln. | Nettowinst (verlies) 2025 * | 603 mln. 83,22 mln. 77,83 mln. | EV/omzet 2024 * | 8,26 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 7,59 x |
K/w-verhouding 2024 * |
28,8
x | K/w-verhouding 2025 * |
26,2
x | Werknemers | 1.444 |
Dividendrendement 2024 * |
0,99% | Dividendrendement 2025 * |
1,12% | Vrij verhandelbaar | 16,25% |
1 dag | -0,29% | ||
1 week | -1,14% | ||
Lopende maand | +8,91% | ||
1 maand | +14,16% | ||
3 maanden | +9,72% | ||
6 maanden | +7,82% | ||
Lopend jaar | -7,13% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Xiao Ming Liang
CEO | Chief Executive Officer | 57 | 06-11-93 |
Hua Cheng Liang
DFI | Director of Finance/CFO | 42 | 01-09-21 |
Zhen Rao
BRD | Director/Board Member | 56 | 06-11-93 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Wei Dong Zhang
BRD | Director/Board Member | 61 | 03-02-21 |
Xiao Ming Liang
CEO | Chief Executive Officer | 57 | 06-11-93 |
Zhen Rao
BRD | Director/Board Member | 56 | 06-11-93 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 31,28 | -0,29% | 4 754 105 |
25-04-24 | 31,37 | -1,07% | 5 096 226 |
24-04-24 | 31,71 | +1,73% | 6 388 069 |
23-04-24 | 31,17 | -1,08% | 3 906 015 |
22-04-24 | 31,51 | -0,41% | 4 949 545 |
slotkoers Shenzhen S.E., 26 april 2024
Meer koersenHerzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-7,13% | 2,18 mld. | |
-4,66% | 86,13 mld. | |
+1,32% | 39,82 mld. | |
-19,27% | 30,42 mld. | |
+57,86% | 25,23 mld. | |
-17,69% | 11,6 mld. | |
-43,00% | 11,51 mld. | |
-9,14% | 11,95 mld. | |
+5,24% | 8,71 mld. | |
-8,42% | 8,12 mld. |